Graft vs Host Disease - 22 Studies Found

Completed : Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease
: Graft vs Host Disease
: 2012-11-25
:
  • Drug: Tacrolimus D-1~D20: iv i
Completed : Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
: Graft vs Host Disease
: 2025-08-03
: Pacritinib will be given as 100 mg or 200 mg tablets to be taken orally twice daily (12 hours apart) on days 1-28 of a 28 day cycle.Morning and
<<< Previous